Concord Medical Services Holdings (CCM) Cost of Revenue (2009 - 2025)

Concord Medical Services Holdings (CCM) has reported Cost of Revenue for 17 consecutive years, with $2.9 million the latest figure, recorded in Q2 2025.

• Cost of Revenue for Q2 2025 came in at $2.9 million, down 14.69% year-over-year; the trailing twelve-month figure through Jun 2025 was $13.9 million (up 6.21% YoY), and the FY2025 annual result was $62.2 million, down 2.03% from the prior year.
• Cost of Revenue was $2.9 million for Q2 2025 at Concord Medical Services Holdings, down from $3.4 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $3.9 million in Q2 2022 and troughed at $2.1 million in Q2 2021.
• Average Cost of Revenue over 5 years is $3.2 million, with a median of $3.4 million recorded in 2024.
• Year-over-year, Cost of Revenue sank 32.33% in 2021 and jumped 86.39% in 2022.
• Over 5 years, Cost of Revenue stood at $2.1 million in 2021, then surged by 86.39% to $3.9 million in 2022, then decreased by 7.83% to $3.6 million in 2023, then declined by 5.45% to $3.4 million in 2024, then declined by 14.69% to $2.9 million in 2025.
• Per Business Quant data, the three most recent Cost of Revenue figures were $2.9 million in Q2 2025, $3.4 million in Q2 2024, and $3.6 million in Q2 2023.